Proclara Biosciences, Inc.
Records under this name other than the patents Proclara Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 6 of 6 · Back to Proclara Biosciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,493,515 | Bacteriophage gene 3 protein compositions and use as amyloid binding agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,493,516 | Bacteriophage gene 3 protein compositions and use as amyloid binding agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,688,728 | Bacteriophage gene 3 protein compositions and use as amyloid binding agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,723,951 | Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,247,055 | General amyloid interaction motif (GAIM) Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,988,444 | Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity Formerly held Lapsed on the fee record Ended Jun 5, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2026 | From the USPTO record |